Clinical trial data review on weight-loss drugs reveals weight regain patterns post-medication discontinuation, impacting weight management strategies.

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a ...

A WOMAN who lost a staggering five stone thanks to weight-loss jabs has hit back at trolls who brand her an “Ozempic cheat”.

Explore how semaglutide and tirzepatide may protect against dementia and stroke—keep reading for clinical implications and evidence.

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

Hydreight will be represented by Shane Madden, Chief Executive Officer, and Shafin Diamond Tejani, Board Chair, who will meet one-on-one with investors and participate in discussions around the ...

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

Atelier Aesthetics, located at 8801 SW 136 St., directly opposite The Falls shopping center, celebrated its grand opening on May 1. The French word “atelier” means workshop or studio used by an artist ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...